Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

Allowing Your Heart to Break as a Cancer Survivor

June 17th 2024, 5:00pm

Article

Experiencing losing a friend to cancer in the cancer community is never easy, but it’s OK to allow your heart to break.

Vaccine-Based Combo Shows Disease Control in CRC

June 4th 2024, 1:00pm

Article

PolyPEPI1018 may boost the efficacy of Tecentriq in certain patients with colorectal cancer.

The Unexpected Joy of Cancer

May 23rd 2024, 1:00pm

Article

My colon cancer diagnosis significantly dwarfed all my other problems.

A Poem: My Colon Cancer Remix

May 19th 2024, 6:00pm

Article

I hope my poem — which outlines my experience being diagnosed with colon cancer — brings light to someone’s day.

Aspirin Linked to Lower Metastasis in Esophageal, Colorectal Cancers

April 25th 2024, 3:00pm

Article

Research has shown aspirin use to be associated with lower rates of metastasis for some patients.

Cancer Taught Me that Family Matters Most

April 19th 2024, 1:00pm

Article

After treatment for colorectal cancer, I wrote this poem to my children because I wasn't sure how much time I had left.

My Oncologist Says I've 'Graduated' from Cancer

April 8th 2024, 5:00pm

Article

After five years of being cancer-free, my oncologist said I'm graduated and can live my life freely.

Moderate Multivitamin Use Associated With Lower CRC Mortality

March 19th 2024, 3:00pm

Article

Moderate multivitamin use was associated with a decreased risk of death in patients with colorectal cancer, though more research is needed, an expert said.

How I Navigate the Lynch Syndrome Labyrinth

March 11th 2024, 5:00pm

Article

Although many hate drinking the prep for colonoscopies, I view it as a privilege.

FDA to Speed Up Review of Krazati Combo for Metastatic CRC

February 20th 2024, 10:00pm

Article

The Food and Drug Administration granted a priority review to Krazati plus Erbitux for KRAS G12C-mutant locally advanced or metastatic colorectal cancer.